Vanguard Group Inc Atri Cure, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,752,985 shares of ATRC stock, worth $108 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,752,985
Previous 4,766,029
0.27%
Holding current value
$108 Million
Previous $170 Million
15.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ATRC
# of Institutions
237Shares Held
46.7MCall Options Held
95.7KPut Options Held
119K-
Black Rock Inc. New York, NY4.23MShares$96.3 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.65MShares$83.2 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.68MShares$61 Million0.48% of portfolio
-
Wellington Management Group LLP Boston, MA1.64MShares$37.3 Million0.01% of portfolio
-
Macquarie Group LTD Australia, C31.41MShares$32.2 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.06B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...